人肾小管上皮细胞necroptosis模型的构建

 目的：以体外培养的人肾小管上皮细胞（HK-2细胞）为靶细胞，构建肾小管上皮细胞凋亡样坏死（necroptosis）的模型。方法：采用肿瘤坏死因子 α (tumor nercosis factor α, TNF-α)诱导细胞凋亡，同时采用抗霉素A (antimycin A)耗竭ATP，构建肾小管上皮细胞凋亡的模型，并以caspase-8抑制剂苄氧羰酰-缬氨酰-丙氨酰-天冬氨酰-氟甲基酮(benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, zVAD-fmk) 阻断凋亡，用necroptosis的特异性抑制剂necrostatin-1（Nec-1）阻断necroptosis，观察细胞在不同的处理下形态学的变化,同时检测细胞存活率及标志物微管相关蛋白1轻链3-Ⅱ（microtubule-associated protein 1 light chain 3-Ⅱ，LC3-Ⅱ）的表达。结果：（1）在TNF-α+zVAD- fmk+antimycin A处理1 h时细胞及细胞器膨胀，电镜下细胞膜碎裂，线粒体变圆、肿胀，嵴逐渐模糊，胞浆中出现大量自噬小体，而Nec-1预处理后细胞的坏死程度较对照组明显改善。（2）在TNF-α+zVAD-fmk+antimycin A 1 h实验组，Nec-1预处理后细胞的存活率显著增加（P<0.05）。（3）TNF-α+zVAD-fmk+antimycin A干预1 h实验组在Nec-1预处理后LC3-Ⅱ的表达量明显下降（P<0.05）。结论：凋亡环境中阻断凋亡可以诱导肾小管上皮细胞necroptosis，抑制剂Nec-1能特异性阻断肾小管上皮细胞发生坏死。

A model of necroptosis in human renal tubular epithelial cells

AIM:To make a model of necroptosis in human renal tubular epithelial HK-2 cells. METHODS:To induce necroptosis, HK-2 cells were treated with tumor necrosis factor α (TNF-α) followed by ATP depletion, and benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD-fmk) was added to block the activity of caspase-8. The morphological changes of the cells were observed under light microscope and electronic microscope.The cell viability was detected by CCK-8 assay, and the marker of necroptosis was analyzed by Western blotting. RESULTS:In the cells treated with TNF-α followed by zVAD-fmk and antimycin A for 1 h, the morphological changes including the cell and organelle inflation, and membrane fragmentation, with a large amount of autophagysome， were observed.However, these abnormalities were markedly attenuated after treatment with Nec-1. Meanwhile, the cell viability was also significantly improved after using Nec-1. No similar variation was observed in other groups. In addition, the expression of LC3-II was significantly decreased in Nec-1+TNF-α+zVAD-fmk+ antimycin A (1 h) group compared with control group. CONCLUSION: TNF-α stimulation and energy depletion induce necroptosis in renal tubular epithelial cells.Nec-1 inhibits necroptosis in a caspase-independent pathway, and may have therapeutic potential to prevent and treat renal ischemia injury.